{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:08:18Z","timestamp":1788869298275,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cllc.2026.07.009","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T15:47:22Z","timestamp":1785167242000},"page":"129-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated Genomic and Immune Profiling of Early Onset Lung Cancer in East Asians Reveals a Distinct Molecular Architecture"],"prefix":"10.1016","volume":"27","author":[{"given":"Jianhua","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cllc.2026.07.009_bib0001","first-page":"229","article-title":"A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"10.1016\/j.cllc.2026.07.009_bib0002","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/s41571-022-00672-8","article-title":"Is early-onset cancer an emerging global epidemic? Current evidence and future implications","volume":"19","author":"Ugai","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"10.1016\/j.cllc.2026.07.009_bib0003","doi-asserted-by":"crossref","first-page":"618","DOI":"10.21147\/j.issn.1000-9604.2023.06.06","article-title":"Lung cancer burden and trends from 2000 to 2018 in China: comparison between China and the United States","volume":"35","author":"Teng","year":"2023","journal-title":"Chin J Cancer Res"},{"key":"10.1016\/j.cllc.2026.07.009_bib0004","doi-asserted-by":"crossref","DOI":"10.1177\/10732748251386505","article-title":"The emerging epidemic of early-onset cancer: global patterns, biological complexity, and urgent calls for action","volume":"32","author":"Lopes-J\u00fanior","year":"2025","journal-title":"Cancer Control"},{"issue":"1","key":"10.1016\/j.cllc.2026.07.009_bib0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/JTO.0b013e3181c41e8d","article-title":"Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis","volume":"5","author":"Subramanian","year":"2010","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.cllc.2026.07.009_bib0006","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1038\/s41467-025-57309-4","article-title":"Comprehensive characterization of early-onset lung cancer, in Chinese young adults","volume":"16","author":"Tian","year":"2025","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.cllc.2026.07.009_bib0007","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.jtho.2025.06.005","article-title":"Genomic profiles of pathogenic and moderate-penetrance germline variants associated with risk of early-onset lung adenocarcinoma","volume":"20","author":"Cho","year":"2025","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.cllc.2026.07.009_bib0008","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1038\/s41467-019-09762-1","article-title":"Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.cllc.2026.07.009_bib0009","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/s41591-021-01450-2","article-title":"Toward personalized treatment approaches for non-small-cell lung cancer","volume":"27","author":"Wang","year":"2021","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.cllc.2026.07.009_bib0010","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41568-019-0179-8","article-title":"Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy","volume":"19","author":"Skoulidis","year":"2019","journal-title":"Nat Rev Cancer"},{"issue":"17","key":"10.1016\/j.cllc.2026.07.009_bib0011","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"Fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"issue":"7463","key":"10.1016\/j.cllc.2026.07.009_bib0012","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"issue":"7463","key":"10.1016\/j.cllc.2026.07.009_bib0013","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"issue":"6312","key":"10.1016\/j.cllc.2026.07.009_bib0014","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1126\/science.aag0299","article-title":"Mutational signatures associated with tobacco smoking in human cancer","volume":"354","author":"Alexandrov","year":"2016","journal-title":"Science"},{"issue":"9 Suppl","key":"10.1016\/j.cllc.2026.07.009_bib0015","article-title":"Clinical significance of ras oncogene activation in human lung cancer","volume":"52","author":"Rodenhuis","year":"1992","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.cllc.2026.07.009_bib0016","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a001008","article-title":"TP53 mutations in human cancers: origins, consequences, and clinical use","volume":"2","author":"Olivier","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"6230","key":"10.1016\/j.cllc.2026.07.009_bib0017","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"issue":"19","key":"10.1016\/j.cllc.2026.07.009_bib0018","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","article-title":"KEYNOTE-024 investigators. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer","volume":"375","author":"Reck","year":"2016","journal-title":"N Engl J Med"},{"issue":"10183","key":"10.1016\/j.cllc.2026.07.009_bib0019","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(18)32409-7","article-title":"Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial","volume":"393","author":"Mok","year":"2019","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.cllc.2026.07.009_bib0020","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1158\/2159-8290.CD-15-0714","article-title":"Homologous recombination deficiency: exploiting the fundamental vulnerability of ovarian cancer","volume":"5","author":"Konstantinopoulos","year":"2015","journal-title":"Cancer Discov"},{"issue":"4","key":"10.1016\/j.cllc.2026.07.009_bib0021","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0092-8674(92)90593-2","article-title":"A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia","volume":"71","author":"Kastan","year":"1992","journal-title":"Cell"},{"issue":"7878","key":"10.1016\/j.cllc.2026.07.009_bib0022","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41586-021-03898-1","article-title":"Structure-based classification predicts drug response in EGFR-mutant NSCLC","volume":"597","author":"Robichaux","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cllc.2026.07.009_bib0023","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1038\/s41467-022-34398-z","article-title":"Biochemical and structural basis for differential inhibitor sensitivity of EGFR with distinct exon 19 mutations","volume":"13","author":"van Alderwerelt van Rosenburgh","year":"2022","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.cllc.2026.07.009_bib0024","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1097-2765(03)00047-9","article-title":"EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization","volume":"11","author":"Ferguson","year":"2003","journal-title":"Mol Cell"},{"issue":"12","key":"10.1016\/j.cllc.2026.07.009_bib0025","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1093\/emboj\/17.12.3385","article-title":"Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers","volume":"17","author":"Lenferink","year":"1998","journal-title":"EMBO J"},{"issue":"5","key":"10.1016\/j.cllc.2026.07.009_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100260","article-title":"Targeting HER2 in non-small-cell lung cancer (NSCLC): a glimpse of hope? An updated review on therapeutic strategies in NSCLC harbouring HER2 alterations","volume":"6","author":"Riudavets","year":"2021","journal-title":"ESMO Open"},{"issue":"31","key":"10.1016\/j.cllc.2026.07.009_bib0027","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.1200\/JCO.23.01361","article-title":"Trastuzumab deruxtecan in patients with HER2-mutant metastatic non-small-cell lung cancer: primary results from the randomized, phase II DESTINY-Lung02 trial","volume":"41","author":"Goto","year":"2023","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.cllc.2026.07.009_bib0028","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.lungcan.2014.12.018","article-title":"Targeting HER2 in the treatment of non-small cell lung cancer","volume":"87","author":"Mar","year":"2015","journal-title":"Lung Cancer"},{"issue":"26","key":"10.1016\/j.cllc.2026.07.009_bib0029","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa1810858","article-title":"Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer","volume":"379","author":"Moore","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.cllc.2026.07.009_bib0030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41571-018-0114-z","article-title":"State-of-the-art strategies for targeting the DNA damage response in cancer","volume":"16","author":"Pili\u00e9","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.cllc.2026.07.009_bib0031","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2147\/OTT.S272199","article-title":"Ovarian cancer therapy: homologous recombination deficiency as a predictive biomarker of response to PARP inhibitors","volume":"15","author":"Miller","year":"2022","journal-title":"Onco Targets Ther"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730426001038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730426001038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:19:18Z","timestamp":1788866358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730426001038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1525730426001038"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2026.07.009","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated Genomic and Immune Profiling of Early Onset Lung Cancer in East Asians Reveals a Distinct Molecular Architecture","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2026.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}